|
DPT Lakewood Warned for Failure Investigation Flubs, Sterility Concerns
DPT Laboratories’ investigations into batch failures at its Lakewood, N.J., plant are inadequate and heighten concern about microbiological contamination of topical drugs, according to an FDA warning letter.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives